Open access
Aug 2026
ARTIFICIAL INTELLIGENCE-ASSISTED DRUG DESIGN COMBINED WITH MOLECULAR DOCKING FOR PRIORITIZATION OF POTENTIAL LEAD MOLECULES ACROSS FIVE THERAPEUTIC TARGETS
The integrated workflow supports computational narrowing of chemical space and target-specific lead prioritization and should be considered computational leads requiring biochemical, cellular, pharmacokinetic and toxicity validation before any therapeutic claim is made.
Harshveer Singh Jaitawat, Dr. Thanugula ShivaPrasad Sharma, Dr. H.S. Udawat et al.
· EPRA International Journal o... · 0 citations